Linagliptin 5 mg Oral Tablet: Clinical Trials

3 trials of Linagliptin 5 mg Oral Tablet, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Unknown 1

Follow Linagliptin 5 mg Oral Tablet: new trials by email Literature Review of Linagliptin 5 mg Oral Tablet trials Research Report on Linagliptin 5 mg Oral Tablet

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai Volunteers
Linagliptin 5 mg Oral Tablet, Trajenta 5 MG Oral Tablet - Healthy Volunteer
Phase 1UnknownInternational Bio service482024-04-242024-02-07
Empagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus
Empagliflozin 25 MG, Linagliptin 5 mg Oral Tablet - Diabetes Mellitus, Kidney Transplant; Complications
Not applicableUnknownMedanta, The Medicity, India2002023-11-102023-10-24
Linagliptin in Post-renal Transplantation
Linagliptin 5 mg Oral Tablet, Insulin - Transplanted Kidney Complication
CompletedUniversidad de Guanajuato282016-01-012019-06-04

Conditions studied

Diabetes Mellitus (1)

Sponsors

International Bio service (1)  ·  Medanta, The Medicity, India (1)  ·  Universidad de Guanajuato (1)

Top investigators

Rodolfo Guardado, MD (1)  ·  Uthai Suvanakoot (1)

Results publications

PMID 15882287, PMID 24279801, PMID 24344941, PMID 25307034, PMID 28533501, PMID 30862658, PMID 31539565